Abstract
We previously reported that 2-fluoroloxoprofen has lower gastric ulcerogenic activity than loxoprofen, a nonsteroidal anti-inflammatory drug (NSAID) without selectivity for COX-2. We synthesized derivatives of 2-fluoroloxoprofen and studied their properties. Compared to 2-fluoroloxoprofen, one derivative, 11a, exhibited higher anti-inflammatory activity and an equivalent ulcerogenic effect. These results suggest that 11a could be therapeutically beneficial for use as an NSAID.
Original language | English |
---|---|
Pages (from-to) | 5143-5150 |
Number of pages | 8 |
Journal | Journal of Medicinal Chemistry |
Volume | 55 |
Issue number | 11 |
DOIs | |
Publication status | Published - 2012 Jun 14 |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery